Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: Implications for programmes?

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 8, 2011, Pages 421-430

  Zachariah, R ^a   Tayler Smith, K ^a   Manzi, M ^a   Massaquoi, M ^a   Mwagomba, B ^b   van Griensven, J ^c   van Engelgem, I ^a   Arnould, L ^d   Schouten, E J ^b,e   Chimbwandira, F M ^b   Harries, A D ^f,g  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MINISTRY OF HEALTH   (Malawi)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d Medical Department   (Belgium)

^e MSF Brussels Operational Centre ^*  (Malawi)

^f INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

ART; Attrition; Kenya; Malawi; Preparation phase; Reporting; Retention

Indexed keywords

EFAVIRENZ; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; DRUG COST; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KENYA; MAJOR CLINICAL STUDY; MALAWI; MALE; MALNUTRITION; PATIENT ATTRITION; PATIENT CARE; PATIENT PARTICIPATION; PATIENT RETENTION; PRETREATMENT PERIOD; RISK FACTOR; SEX DIFFERENCE; THERAPY;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; MALAWI; MALE; MIDDLE AGED; PATIENT DROPOUTS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79960287516     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.04.014     Document Type: Article

References (23)

1. Rosen S., Fox M.P., Gill C.J. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007, 4:e298.
2. Lawn S.D., Myer L., Harling G., Orrell C., Bekker L.G., Wood R. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 2006, 43:770-776.
3. Lawn S.D., Myer L., Orrell C., Bekker L.G., Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005, 19:2141-2148.
4. Amuron B., Namara G., Birungi J., Nabiryo, Levin C., Grosskurth J., et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 2009, 9:290.
5. WHO. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2006 revision. Geneva: World Health Organization; 2006. [accessed 19 April 2011]. http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf.
6. National AIDS and STI Control Programme (NASCOP). Guidelines for antiretroviral drug therapy in Kenya. 3rd ed. Nairobi: Ministry of Health; 2005. [accessed 14 March 2010]. http://apps.who.int/medicinedocs/documents/s16742e/s16742e.pdf.
7. Ministry of Health and Population (MOHP) and National AIDS Commission. Guidelines for the use of antiretroviral therapy in Malawi. 2nd ed. Lilongwe: Ministry of Health; 2006.
8. Yu J.K., Tok T.S., Tsai J.J., Chang W.S., Dzimadzi R.K., Yen P.H., et al. What happens to patients on antiretroviral therapy who transfer out to another facility?. PLoS One 2008, 3:e2065.
9. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies [in German]. Internist (Berl) 2008, 49:688-693.
10. Harries A.D., Rusen I.D., Chiang C.Y., Hinderaker S.G., Enarson D.A. Registering initial defaulters and reporting on their treatment outcomes. Int J Tuberc Lung Dis 2009, 13:801-803.
11. Weller I. Delivery of antiretroviral therapy in sub-Saharan Africa. Clin Infect Dis 2006, 43:777-778.
12. WHO. Patient monitoring guidelines for HIV care and antiretroviral therapy (ART). Geneva: World Health Organization; 2006. [accessed 14 March 2010]. http://www.who.int/3by5/capacity/ptmonguidelinesfinalv1.PDF.
13. Yu J.K., Chen S.C., Wang K.Y., Chang, Makombe C.S., Schouten E.J., et al. True outcomes for patients on antiretroviral therapy who are 'lost to follow-up' in Malawi. Bull World Health Organ 2007, 85:550-554.
14. Fox M.P., Brennan A., Maskew M., MacPhail P., Sanne I. Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health 2010, 15:405-413.
15. Ingle S. Pre-treatment mortality and probability of starting ART in patients enrolled in the free state ARV program, South Africa. Implications for treatment guidelines. In: 17th Conference on Retroviruses and Opportunistic Infections (CROI); 16-19 February 2010; San Francisco, CA. Abstract 108.
16. Unge C., Sodergard B., Ekstrom A.M., Carter J., Waweru M., Ilako F., et al. Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya. J Acquir Immune Defic Syndr 2009, 50:397-402.
17. Zachariah R., Teck R., Buhendwa L., Fitzerland M., Labana S., Chinji C., et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg 2007, 101:79-84.
18. Zachariah R., Fitzgerald M., Massaquoi M., Pasulani O., Arnould L., Makombe S., et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006, 20:2355-2360.
19. Zachariah R., Harries K., Moses M., Manzi M., Line A., Mwagomba B., et al. Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi. Trop Med Int Health 2009, 14:713-721.
20. Zachariah R., Teck R., Ascurra O., Gomani P., Manzi M., Humblet P., et al. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?. Int J Tuberc Lung Dis 2005, 9:238-247.
21. Philips M., Zachariah R., Venis S. Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea. Lancet 2008, 371:682-684.
22. WHO. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. Geneva: World Health Organization; 2009. [accessed 14 March 2010]. http://www.who.int/hiv/pub/arv/advice/en/.
23. Braitstein P., Brinkhof M.W., Dabis F., Schechter M., Boulle A., Miotti P., et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006, 367:817-824.